Post-Market
Field Safety Corrective Action(FSCA)
In one line
Action taken to reduce a risk of serious deterioration in health associated with a device.
Definition
An FSCA is any action taken by a manufacturer to reduce the risk of a serious incident in relation to a device already placed on the market, including device modifications, exchange, return, destruction, or advice to users (FSN).
Under the EU MDR, FSCAs must be reported to the competent authorities before being carried out, except in urgent cases, and communicated to users through a field safety notice (FSN) whose content authorities can review. The FSN should explain the problem, the risk, and what users must do. In the US, comparable actions are generally handled as recalls or as corrections and removals under 21 CFR Part 806.
Why it matters
FSCAs are reported to Competent Authorities in the EU and may correspond to FDA recalls, depending on classification.
Common pitfalls
- •A common pitfall is failing to promptly initiate an FSCA when new risk information emerges, potentially leading to more severe patient harm and regulatory penalties.
- •Manufacturers sometimes incorrectly assume that minor product updates do not require an FSCA, even if they address a potential safety concern.
- •Not all product changes or customer communications qualify as an FSCA, leading to confusion about reporting obligations.
- •Failure to adequately communicate the FSCA to all affected parties, including users and distributors, can undermine its effectiveness.
- •Inadequate documentation of the FSCA process and its outcomes can lead to compliance issues during audits.
Sources
- MDCG Vigilance Guidance · MDCG
- FDA MAUDE Database · FDA
- FDA Recalls - Medical Devices · FDA